Working
Group Session
"The Challenge For Biotech: Shaping The Future Of Clinical
Trials"
WEDNESDAY,
MAY 8, 2002
Moderated by
Dr. C. Budd Colby, Colby Biomedical Consultants
Click here for the Summary on
this Working Group Session in PDF format.
(Adobe
Acrobat Reader is needed to view this document)
Invitation-only. 3:00 - 5:30 p.m.
The objective
of the Working Group session is to gather 8-10 thought leaders to
exchange knowledge on the pain points (challenges) currently faced
by biotech companies in structuring and processing clinical trials.
The solutions biotech companies are using to meet these challenges
will also be discussed as well as what critical technology solutions
are still needed.
The pace of
new drug development and rapid growth of biotech companies means
a surge in clinical trials -- the expensive and time consuming process
of testing medical drugs. Clinical trials, occurring in three overlapping
phases and last several years each, are used not only to demonstrate
the drug's efficacy, but also to determine its risks and side effects,
measure effective doses, test various methods for delivering the
drug, and even experiment with different manufacturing methods.
The right strategic business decisions and compliance with the U.S.
Food and Drug Administration's Center for Drug and Evaluation Research
(CDER) are key to the success of clinical trials, inevitably getting
new drugs to the U.S. market. With the rapid pace of new drug development
and plethora of biotech companies, what is the impact on the structure
and process of clinical trials?
The following
questions, among others, will be discussed at this Working Group
over wine and light hors d'oeuvres:
What
are the most felt pain points (challenges) faced by biotech companies
with structuring and processing clinical trials in:
1) Patient acquisition and case
management;
2) Data acquisition, storage,
retrieval, and mining; and
3) Data analysis.
What
technology solutions are biotech companies using to address these
pain points?
What
technology solutions are critically needed that to do not currently
exist?
FOR
FURTHER INFORMATION
This
Working Group session is invitation-only. Individuals who are interested
in possible participation and represent biotech companies that are
involved in clinical trials, send your name, company, bio, email,
and telephone number to:
Dr. Venilde
Jeronimo
Senior Director, Client Services
Silicon Valley World Internet Center
mailto:venilde@worldinternetcenter.com
T: 650.462.9800
Or
Ms. Claire Kahrobaie
Manager, Client Services
Silicon Valley World Internet Center
mailto:kahrobaie@worldinternetcenter.com
T: 650.462.9800
top
|